Content (1076)
-
White papersEngaging on independent director access in Asia
Asian companies are beginning to recognise the value of structured dialogue between independent directors and long-term shareholders. Haonan Wu and Jaime Gornsztejn identify the factors driving this trend, and explain the benefits for all parties.
-
White papersMitigating AI risks to children
Artificial intelligence is being rolled out at pace, but regulators are one step behind. Children and young people are among the most vulnerable users of this new technology. Ross Teverson and Navishka Pandit outline the key risks, and ways to mitigate them.
-
White papersMDT: How we seek to enhance our alpha model
Elegance is an essential part of the process.
-
White papersConsider currency correlation
Currency can bring diversification, but not if the countries react similarly to events.
-
White papersThe presence of absence
Powell will no longer speak from the podium, but by remaining on the Fed board, his voice remains.
-
White papersPublic Engagement Report Q1 2026
The Q1 Public Engagement Report from EOS at Federated Hermes Limited explores how Asian companies are improving access to independent directors for investors, ways to mitigate AI risks to children, and efficiency challenges for the aviation sector.
-
White papersChina: a trot, not a gallop – so far
China’s stock market has lagged peers this year. Why has the country been left behind?
-
White papersSeizing climate-related opportunities: Climate Change High Yield Credit, Annual Report 2025
Investor engagement plays a critical role, particularly with companies in high-carbon sectors.
-
VideoHow has quant investing evolved over time?
In this short video, Daniel Mahr, Head of MDT Group, explores how quantitative investing has evolved – from early factor models to today’s data‑rich, machine‑learning‑driven strategies.
-
White papersBack to those other bricks
With Middle East peace in sight, the S&P 500 should resume its path to 7,500.
-
White papersPortfolio manager Q&A: MDT Market Neutral
We asked Dan Mahr, Head of MDT, to discuss MDT’s market neutral strategy — its history, approach and how it may fit within a portfolio. Please find edited excerpts from the conversation below.
-
White papersBiotechs and the potential AI advantage
AI won’t replace biotech — it will supercharge it.
